Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 1b/Randomized Phase 2 Study to Evaluate LY3039478 in Combination With Dexamethasone in T-ALL/T-LBL Patients

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT02518113
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:37:35.300161+00:00
Published At
2019-02-06T00:00:00+00:00
Record Updated At
2019-09-11
Results Posted At
2019-02-06
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["T-cell Acute Lymphoblastic Leukemia", "T-cell Lymphoblastic Lymphoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2019-09-11"
protocolSection.identificationModule.nctId
"NCT02518113"
protocolSection.identificationModule.officialTitle
"A Phase 1b/Randomized Phase 2 Study to Evaluate LY3039478 in Combination With Dexamethasone in T-ALL/T-LBL Patients"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE1", "PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2019-02-06"

Study condition terms

  • T-cell Acute Lymphoblastic Leukemia (protocolSection.conditionsModule.conditions)
  • T-cell Lymphoblastic Lymphoma (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.